Services

Services

Thought Leadership

About Us

All Conferences

ISPOR 2022

April 2022

HealthCore is a proud sponsor of ISPOR 2022: the leading global conference for health economics and outcomes research! Visit us at Booth #500 (or virtually), connect with our experts, and see our latest research.

Both in-person and virtual conference registration includes extended access to all session playback recordings as well as virtual posters and networking through June 17, 2022. For more information, please visit https://www.ispor.org/conferences-education/conferences/upcoming-conferences/ispor-2022.

Workshop

Concurrent Breakout Session 5 | Tuesday, May 17 | 1:30–2:30 pm ET

219 | Best Practices for Causal Study Designs Using Real-World Data

Discussion Leader: Michael Grabner, PhD¹
Discussants: Nilesh Gangan, PhD¹, Susan dosReis, PhD²
¹HealthCore, Inc., Wilmington, DE, USA, ²University of Maryland School of Pharmacy, Baltimore, MD, USA

HealthCore ISPOR 2022 Causality Workshop [PDF]

HealthCore Poster Presentations

Sunday, May 15 – Wednesday, May 18

Click the title of each poster below to view the abstract.
*HealthCore authors are indicated in bold.

Session	Topic	Title	Authors	Affiliations
Monday, May 16 Poster Session 1 12:15 – 1:15 PM EDT	CLINICAL OUTCOMES / DIABETES / ENDOCRINE / METABOLIC DISORDERS	CO30 \| Clinical Experiences of Type 2 Diabetes (T2DM) Patients Initiating Oral Semaglutide	Dunn TJ¹, Swift C¹, Guesnier A¹, Noone J¹, Willey V²	¹Novo Nordisk Inc., Plainsboro, NJ, USA, ²HealthCore, Inc., Wilmington, DE, USA
Monday, May 16 Poster Session 1 12:15 – 1:15 PM EDT	METHODOLOGICAL & STATISTICAL RESEARCH / NO ADDITIONAL DISEASE & CONDITIONS / SPECIALIZED TREATMENT AREAS	MSR11 \| A Step-By-Step Guide for Causal Study Design When Estimating Treatment Effects Using Real-World Data HealthCore ISPOR 2022 Causality Poster [PDF] Causal Study Design Guide and Glossary [PDF]	Hoffman S¹, Gangan N¹, Chen X², Smith JL¹, Tave A¹, Yang Y¹, dosReis S³, Grabner M¹	¹HealthCore, Inc., Wilmington, DE, USA, ²Anthem, Inc., Indianapolis, IN, USA, ³University of Maryland School of Pharmacy, Baltimore, MD, USA
Tuesday, May 17 Poster Session 3 12:15 – 1:15 PM EDT	CLINICAL OUTCOMES / DIABETES / ENDOCRINE / METABOLIC DISORDERS Top 5% Finalist for the ISPOR 2022 Research Presentation Awards	CO94 \| Changes in Demographic and Clinical Characteristics of Patients with Type 2 Diabetes (T2DM) Initiating Subcutaneous Semaglutide	Dunn TJ¹, Swift C¹, Guesnier A¹, Noone J¹, Willey V²	¹Novo Nordisk Inc., Plainsboro, NJ, USA, ²HealthCore, Inc., Wilmington, DE, USA
Tuesday, May 17 Poster Session 3 12:15 – 1:15 PM EDT	ECONOMIC EVALUATION / DIABETES / ENDOCRINE / METABOLIC DISORDERS	EE242 \| Economic Burden Among Chronic Kidney Disease (CKD) Patients with and without Type 2 Diabetes (T2D) in a Commercially Insured/Medicare Advantage (MA) Population in the United States (US)	Chung H¹, Thomas N¹, Willey V¹, Kong SX², Singh R², Farej R², Williamson T²	¹HealthCore, Inc., Wilmington, DE, USA, ²Bayer U.S. LLC, Whippany, NJ, USA
Tuesday, May 17 Poster Session 4 5:30 – 6:30 PM EDT	REAL WORLD DATA & INFORMATION SYSTEMS / NO ADDITIONAL DISEASE & CONDITIONS / SPECIALIZED TREATMENT AREAS	RWD106 \| Characterizing Telehealth Utilization from Administrative Claims in the US Using a Standardized Definition	Avula R¹, Grabner M¹, Eshete B¹, Stanek E², Willey V¹	¹HealthCore, Inc., Wilmington, DE, USA, ²Anthem, Inc., Indianapolis, IN, USA
Wednesday, May 18 Poster Session 5 9:00 – 10:00 AM EDT	CLINICAL OUTCOMES / MEDICAL DEVICES Top 5% Finalist for the ISPOR 2022 Research Presentation Awards	CO158 \| A Comparison of the Clinical and Economic Outcomes Associated with Short-Acting Bronchodilator Modes of Delivery Among Patients with Chronic Obstructive Pulmonary Disease (COPD)	Pham T¹, Chen X¹, Talavera M¹, Napier M¹, Willey V²	¹Anthem, Inc., Indianapolis, IN, USA, ²HealthCore, Inc., Wilmington, DE, USA

*Registration is required to visit our booth (in person or virtually).